2022
DOI: 10.1016/j.jnutbio.2022.109147
|View full text |Cite
|
Sign up to set email alerts
|

Crosstalk between xanthine oxidase (XO) inhibiting and cancer chemotherapeutic properties of comestible flavonoids- a comprehensive update

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 8 publications
(3 citation statements)
references
References 517 publications
0
3
0
Order By: Relevance
“…Xanthine oxidase (XOD, EC 1.17.3.2) is the key enzyme in purine metabolism that converts hypoxanthine and xanthine into uric acid while producing H 2 O 2 in living organisms . Inhibiting XOD activity is an effective strategy to reduce uric acid production, making it a promising target for hyperuricemia treatment . Although allopurinol, febuxostat, and other drugs that inhibit XOD activity are being used in clinical trials to treat hyperuricemia, they have inevitable side effects that can endanger patients’ health. , Therefore, there is still a need to develop more potent drug candidates with reduced toxicity to treat hyperuricemia.…”
Section: Introductionmentioning
confidence: 99%
“…Xanthine oxidase (XOD, EC 1.17.3.2) is the key enzyme in purine metabolism that converts hypoxanthine and xanthine into uric acid while producing H 2 O 2 in living organisms . Inhibiting XOD activity is an effective strategy to reduce uric acid production, making it a promising target for hyperuricemia treatment . Although allopurinol, febuxostat, and other drugs that inhibit XOD activity are being used in clinical trials to treat hyperuricemia, they have inevitable side effects that can endanger patients’ health. , Therefore, there is still a need to develop more potent drug candidates with reduced toxicity to treat hyperuricemia.…”
Section: Introductionmentioning
confidence: 99%
“…[100], 626 [41], 627 [10], 723 [6], 661 [3], 1251 [3] MS 2 [625]: 300 [100], 301 [73], 445 [33], 505 [17], 271 [16], 463 [11], 355 [9], 255 [8], 343 [8], 299 [6], 325 [5], 273 [4], 409 [4], 427 [4], 367 [3] MS 3 [625 → 300]: 271 [100], 255 [61], 272 [12], 254 [7], 243 [3] MS 2 [723]: 625 [100], 399 [34], 437 [21], 687 [21], 685 [21]. 437 [21] MS 3 [723 → 625]: 300 [100], 301 [76], 445 [40], 271 [17], 505 [17], 463 [13] MS 2 [23], 211 [16],…”
Section: Compounds Ms (M/z) [Relative Intensity] Ms N (M/z) [Relative...mentioning
confidence: 99%
“…If uric acid crystals are overproduced, the inflammatory response can be triggered, resulting in joint arthritis known as gout. XO is also responsible for generating oxygen-derived free radicals that may result in an imbalance between pro-oxidants and antioxidants, causing some people to be more prone to diseases such as cancer [23]. Anti-gout drugs (e.g., allopurinol), acting as inhibitors of XO activity, may have some side effects such as hepatitis, nephropathy and allergic reactions.…”
Section: Introductionmentioning
confidence: 99%